PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine - Hematology and Oncology, Masaryk University, Brno, Czech Republic.\', \'Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.\', \'Department of Haemato-oncology, University Hospital Ostrava, Ostrava, Czech Republic.\', \'Department of Haemato-oncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.\', \'4th Department of Internal Medicine-Hematology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.\', \'Institute of Hematology and Blood Transfusion, Prague, Czech Republic.\', \'Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacký University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic.\', \'Department of Haematology and Oncology, University Hospital Pilsen, Pilsen, Czech Republic.\', \'Department of Internal Medicine and Haematology, University Hospital Královské Vinohrady and Third Faculty of Medicine, Charles University, Prague, Czech Republic.\', \'Department of Hematology, Silesian Hospital in Opava, Opava, Czech Republic.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/hon.2974
?:hasPublicationType
?:journal
  • Hematological oncology
is ?:pmid of
?:pmid
?:pmid
  • 35120267
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.605
?:rankingScore_hIndex
  • 41
is ?:relation_isRelatedTo_publication of
?:title
  • Successful early use of anti-SARS-CoV-2 monoclonal neutralizing antibodies in SARS-CoV-2 infected hematological patients - A Czech multicenter experience.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all